Objectives: The objectives of this study were to examine simulator driving and subjective sleepiness after morning, afternoon, and night shifts and to compare these differences, as well as objective stress, between a fast-forward and a slow-backward rotating shift system.
Methods: The participants were male volunteers working in a chemical plant, 18 in a slow-backward rotating system and 18 in a fast-forward rotating system. All of the participants performed a driving simulator test and subjectively estimated sleepiness after a night, afternoon, and morning shift. Salivary cortisol samples, as indicators of the objective stress level, at the beginning of the workweek-after the second morning shift-were compared between the two rotating shift systems.
Results: Lane drifting was higher after a night shift than after an afternoon shift. No effect of rotation system on driving performance could be shown. The subjective sleepiness scores were significantly higher in the slow-backward rotating group than in the fast-forward rotating group. A significant effect of shift type was also observed, with lower levels of sleepiness after the afternoon shift than after the morning and night shifts. Salivary cortisol samples taken at the start of the workweek did not significantly differ between the fast-forward and the slow-backward rotation shift systems.
Conclusions: This study indicated that shift type is more important than shift schedule-direction and speed of rotation-in determining driving performance. Performance seemed to be threatened mostly by a night shift and the least by an afternoon shift. In contrast, subjective sleepiness also differed between rotation groups and indicated an advantage of the fast-forward rotation system. The exploratory salivary cortisol measurements suggested that the shift systems studied do not differ in the level of stress they induce, that is to say at the beginning of the workweek.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5271/sjweh.1064 | DOI Listing |
Alzheimers Dement
December 2024
NYU Grossman School of Medicine, New York, NY, USA.
Background: Subjective cognitive decline (SCD) is a preclinical stage of Alzheimer's disease (AD), with correlations to cerebral amyloid and tau and accelerated cognitive decline. Studies have also revealed an association between sleep fragmentation and such AD biomarkers and cognitive decline, suggesting that cognitive function should be monitored in individuals experiencing excessive sleepiness. It is unclear if and how sleep dysfunction relates to SCD apart from AD biomarkers, as well as symptoms related to SCD and sleep dysfunction, such as depression.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Background: Changes in sleep are common in older persons and have been linked to higher dementia risk. The link between sleep complaints and early risk markers of Alzheimer's disease (AD), namely subjective changes in cognition and mild behavioral impairment (MBI), have not been fully explored. This study investigated associations between sleep complaints with cognitive and behavioral AD risk markers and quality of life (QoL) among cognitively unimpaired older persons.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Background: Sleep apnea is associated with risk of objectively-measured cognitive decline and dementia, as well as with subjective cognitive decline (SCD), itself a risk factor for cognitive decline and dementia. This relationship is understudied in ethnoracially diverse groups, however, including Latinos. This study examined associations among self-reported sleep apnea risk, SCD, and cognitive performance in community-dwelling older Latino adults.
View Article and Find Full Text PDFJ Clin Sleep Med
December 2024
Sleep Disorders & Research Center, Department of Sleep Medicine, Henry Ford Health System, Detroit, MI.
Study Objectives: Here we report our experience treating patients with narcolepsy using benzodiazepine receptor agonists (BzRA), zolpidem (Zol) or eszopiclone (Esz) taken at bedtime for both excessive daytime sleepiness (EDS) and cataplexy.
Methods: We reviewed the medical records of 53 patients diagnosed with narcolepsy, between 2002 and 2023. Twenty-three patients, 8 with type1 (NT1), 13 with type 2 (NT2) and 2 with secondary narcolepsy, were treated with BzRA's (20 Zol and 3 Esz).
Neurol Sci
December 2024
University of Central Lancashire, Preston, UK.
Introduction: Functional neurological disorders (FND) are conditions marked by disruptions in brain network function without structural abnormalities. Sleep disturbances, though under-researched, are commonly observed in FND patients and may worsen symptoms and overall health.
Methods: This systematic review had been registered prospectively in PROSPERO with the registration number: CRD42023446306.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!